Cardiac and renal antioxidant enzymes and effects of tempol in hyperthyroid rats

American Journal of Physiology - Endocrinology and Metabolism

Volumn 289, Issue 5 52-5, 2005, Pages

  Moreno, Juan Manuel ^a   Rodríguez Gómez, Isabel ^a   Wangensteen, Rosemary ^b   Osuna, Antonio ^a   Bueno, Pablo ^a   Vargas, Félix ^a,c  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^b UNIVERSITY OF JAÉN   (Spain)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Antioxidant enzymes; Hypertension; Hyperthyroidism; Oxidative stress; Tempol

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TEMPOL; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; ENZYME ACTIVITY; HEART FUNCTION; HYPERTENSION; HYPERTHYROIDISM; KIDNEY CORTEX; KIDNEY FUNCTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE;

ANIMALS; ANTIOXIDANTS; BLOOD PRESSURE; CATALASE; CYCLIC N-OXIDES; DINOPROST; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HEART RATE; HYPERTENSION; HYPERTHYROIDISM; KIDNEY; MALE; MALONDIALDEHYDE; MYOCARDIUM; RATS; RATS, WISTAR; SPIN LABELS; SUPEROXIDE DISMUTASE; THYROXINE;

EID: 27144449315     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00611.2004     Document Type: Article

References (36)

1. Aebi H. Catalase in vitro. Methods Enzymol 105: 121-126, 1984.
2. Asayama K, Dobashi K, Hayashibe H, and Kato K. Effects of beta-adrenergic blockers with different ancillary properties on lipid peroxidation in hyperthyroid rat cardiac muscle. Endocrinol Jpn 36: 687-694, 1989.
3. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
4. Bradley SE, Stephan F, Coelho JB, and Reville P. The thyroid and the kidney. Kidney Int 6: 346-365, 1974.
5. Carlberg I and Mannervik B. Glutathione reductase. Methods Enzymol 113:484-490, 1985.
6. 1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats. Clin Sci (Colch) 106: 251-259, 2004.
7. 6a. Clair DK and Chow CK. Glutathione peroxidase: activity and steady-state level of mRNA. In: Free Radicals: A Practical Approach, edited by Punchard NA and Kelli FJ. London: Oxford Univ Press, 1996, p. 227-240.
8. Esterbauer H and Cheeseman KH. Determination of aldehydic lipid peroxidation product: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 186: 407-421, 1990.
9. Garcia-Estafi J, Atucha N, Quesada T, and Vargas F. Involvement of the renin-angiotensin system in the reduced pressure-natriuresis response of hyperthyroid rats. Am J Physiol Endocrinol Metab 268: E897-E901. 1995.
10. Giavarotti S, Rodrigues L, Rodrigues T, Junqueira VB, and Videla LA. Liver microsomal parameters related to oxidative stress and antioxidant systems in hyperthyroid rats subjected to acute lindane treatment. Free Radic Res 29: 35-42, 1998.
11. Gredilla R, Barja G, and Lopez-Torres M. Thyroid hormone-induced oxidative damage on lipids, glutathione and DNA in the mouse heart. Free Radic Res 35: 417-425, 2001.
12. Griendling KK, Sorescu D, and Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501, 2000.
13. Huh K, Kwon TH, Kim JS, and Park JM. Role of the hepatic xantine oxidase in thyroid dysfunction: effect of thyroid hormones in oxidative stress in rat liver. Arch Pharmacol Res (Seoul) 21: 236-240, 1998.
14. Huie RE and Padmaja S. The reaction of NO with Superoxide. Free Radic Res Commun 18: 195-199, 1993.
15. Kim KM, Paeng KJ, Hahm JR, Kim DR, and Chung BC. Elevated urinary 8-isoprostaglandin F2α in females with Graves' hyperthyroidism. Prostaglandins Leukot Essent Fatty Acids 71: 143-147, 2004.
16. Klein I and Ojamaa K. Thyroid hormone and blood pressure regulation. In: Hypertension: Pathophysiology, Diagnosis and Management (2nd ed.), edited by Laragh JH and Brenner BN. New York: Raven, 1995. p. 2247-2262.
17. Larsen PR, Davis TF, and Hay ID. The thyroid gland. In: Williams Textbook of Endocrinology (6th ed.), edited by Wilson JD, Foster DW, Kronenberg HK, and Larsen PR. London: Saunders, 1998, p. 389-515.
18. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the Folin-phenol reagent. J Biol Chem 193: 265-275, 1951.
19. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
20. Mitchell JB, Samuni A, Krishna MC, DeGraff WG, Ahn MS, Samuni U, and Russo A. Biologically active metal-independent Superoxide dismutase mimetics. Biochemistry 29: 2802-2807, 1990.
21. Mori T and Cowley AW Jr. Renal oxidative stress in medullary thick ascending limbs produced by elevated NaCl and glucose. Hypertension 43: 341-346, 2004.
22. Roberts LJ and Morrow JD. The generation and actions of isoprostanes. Biochim Biophys Acta 1345: 121-135, 1997.
23. Rodríguez-Gómez I, Sainz J, Wangensteen R, Moreno JM, Duarte J, Osuna A, and Vargas F. Increased pressor sensitivity to chronic nitric oxide deficiency in hyperthyroid rats. Hypertension 42: 220-225, 2003.
24. Sainz J, Wangensteen R, Rodríguez-Gómez I, Moreno JM, Chamorro V, Osuna A, Bueno P, and Vargas F. Antioxidant enzymes and effects of tempol. a membrane permeable radical scavenger, on the development of NO inhibition induced-hypertension. Am J Hypertens 18: 871-877, 2005.
25. Sawant BU, Nadkarni GD, Thakare UR, Joseph LJ, and Rajan MG. Changes in lipid peroxidation and free radical scavengers in kidney of hypothyroid and hyperthyroid rats. Indian J Exp Biol 41: 1334-1337, 2003.
26. 2α. Hypertension 33: 424-428, 1999.
27. Sewerynek J, Wiktorska J, Novak D, and Lewinski A. Methimazole protection against oxidative stress induced by hyperthyroidism in Graves disease. Endocr Regul 34: 83-89, 2000.
28. Seymen HO, Civelek S, Seven A, Yigit G, Hatemi H, and Burkak G. Iron supplementation in experimental hyperthyroidism: effects of oxidative stress in skeletal muscle tissue. Yonsei Med J 45: 413-418, 2004.
29. Seymen HO, Seven A, Civelek S, Yigit G, Hatemi H, and Burkak G. Evaluation of antioxidant status in liver tissues: effects of iron supplementation in experimental hyperthyroidism. J Basic Clin Physiol Pharmacol 10: 315-325, 1999.
30. Shokoji T, Nishiyama A, Fijisawa Y, Hitomi H, Kiyomoto H, Takahashi N, Kimura S, Kohno M, and Abe Y. Renal sympathetic nerve responses to tempol in spontaneously hypertensive rats. Hypertension 41: 266-273, 2003.
31. 2α, in the rat, J Clin Invest 90: 136-141, 1992.
32. Tapia G, Cornejo P, Fernández V, and Videla LA. Protein oxidation in the thyroid hormone-induced liver oxidative stress: relation to lipid peroxidation. Toxicol Lett 106: 209-214, 1999.
33. Vargas F, Baz MJ, Luna JD, Andrade J, Jodar E, and Haro JM. Urinary excretion of digoxin-like immunoreactive factor and arginine vasopressin in hyper- and hypothyroid rats. Clin Sci (Colch) 81: 471-476, 1991.
34. Venditti P, Balestrieri M, Di Meo S, and De Leo T. Effect of thyroid state on lipid peroxidation, antioxidant defences, and susceptibility to oxidative stress in rat tissues. J Endocrinol 155: 151-157, 1997.
35. Wilcox CS. Reactive oxygen species: roles in blood pressure and kidney function. Curr Hypertens Rep 4: 160-166, 2002.
36. Zou AP, Li N, and Cowley AW Jr. Production and action of Superoxide in renal medulla. Hypertension 37: 547-553, 2001.